| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 5 Feb 2026 | 21 Jan 2026 |
| Sequent Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025. We refer to our letter dated January 21, 2026, regarding the meeting of the Board of Directors (Board) of the Company scheduled to be held on Thursday, February 05, 2026 and in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 (SEBI Listing Regulations), we hereby inform you that the Board at its meeting held today (As Per BSE Announcement Dated On : 05.02.2026) | ||
| Board Meeting | 16 Dec 2025 | 16 Dec 2025 |
| Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2025 (SEBI Listing Regulations) and outcome of board meeting of the Company. | ||
| Board Meeting | 14 Nov 2025 | 3 Nov 2025 |
| Sequent Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday November 14 2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025. Outcome of Board Meeting held on Friday, November 14, 2025, (As per BSE Announcement dated on: 14.11.2025) | ||
| Board Meeting | 5 Sep 2025 | 5 Sep 2025 |
| Please refer attachment | ||
| Board Meeting | 8 Aug 2025 | 31 Jul 2025 |
| Sequent Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 8 2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025. Outcome of Board Meeting held on Friday, August 08, 2025, along with Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2025 (As per BSE Announcement Dated on 08/08/2025) | ||
| Board Meeting | 20 May 2025 | 8 May 2025 |
| Sequent Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 20 2025 inter alia to: a)consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025. b)recommend dividend if any on the equity shares of the Company for the year ended March 31 2025. Outcome of Board meeting Dt. May 20, 2025 To conserve resources, the Board has not recommended any dividend for FY 2024-25. The Company is not a Large Corporate for FY 2025-26. (As Per BSE Announcement Dated on 20.05.2025) | ||
Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
